These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7078425)

  • 1. The independent synthesis of intermediate density lipoproteins in type III hyperlipoproteinemia.
    Reardon MF; Poapst ME; Steiner G
    Metabolism; 1982 May; 31(5):421-7. PubMed ID: 7078425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjects.
    Packard CJ; Clegg RJ; Dominiczak MH; Lorimer AR; Shepherd J
    J Lipid Res; 1986 Sep; 27(9):930-8. PubMed ID: 3783047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma apolipoprotein B metabolism in familial type III dysbetalipoproteinaemia.
    Turner PR; Cortese C; Wootton R; Marenah C; Miller NE; Lewis B
    Eur J Clin Invest; 1985 Apr; 15(2):100-12. PubMed ID: 3922766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL.
    Fisher WR; Zech LA; Bardalaye P; Warmke G; Berman M
    J Lipid Res; 1980 Aug; 21(6):760-74. PubMed ID: 7419987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct synthesis of low-density lipoprotein apoprotein B in the miniature pig.
    Huff MW; Telford DE
    Metabolism; 1985 Jan; 34(1):36-42. PubMed ID: 3965861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a high carbohydrate diet on apoprotein-B catabolism in man.
    Ginsberg HN; Le NA; Melish J; Steinberg D; Brown WV
    Metabolism; 1981 Apr; 30(4):347-53. PubMed ID: 7207206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of human intermediate and very low density lipoprotein subfractions from normal and dysbetalipoproteinemic plasma. In vivo studies in rat.
    Musliner TA; McVicker KM; Iosefa JF; Krauss RM
    Arteriosclerosis; 1987; 7(4):408-20. PubMed ID: 3606468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
    Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compositional and metabolic heterogeneity of alpha 2- and beta-very-low-density lipoproteins in subjects with broad beta disease and endogenous hypertriglyceridemia.
    Kushwaha RS; Haffner SM; Foster DM; Hazzard WR
    Metabolism; 1985 Nov; 34(11):1029-38. PubMed ID: 4058307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDL, VLDL, chylomicrons and atherosclerosis.
    Nordestgaard BG; Tybjaerg-Hansen A
    Eur J Epidemiol; 1992 May; 8 Suppl 1():92-8. PubMed ID: 1505659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of VLDL apoprotein B by acetaldehyde alters apoprotein B metabolism.
    Kervinen K; Hörkkö S; Beltz WF; Kesäniemi A
    Alcohol; 1995; 12(3):189-94. PubMed ID: 7639949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
    Sandholzer C; Feussner G; Brunzell J; Utermann G
    J Clin Invest; 1992 Nov; 90(5):1958-65. PubMed ID: 1430218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
    Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overproduction of a kinetic subclass of VLDL-apoB, and direct catabolism of VLDL-apoB in human endogenous hypertriglyceridemia: an analytical model solution of tracer data.
    Eaton RP; Allen RC; Schade DS
    J Lipid Res; 1983 Oct; 24(10):1291-303. PubMed ID: 6644179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia).
    Haffner SM; Kushwaha RS; Hazzard WR
    Eur J Clin Invest; 1989 Oct; 19(5):486-90. PubMed ID: 2511026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.
    Milne RW; Weech PK; Blanchette L; Davignon J; Alaupovic P; Marcel YL
    J Clin Invest; 1984 Mar; 73(3):816-23. PubMed ID: 6368590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins.
    Beltz WF; Kesäniemi YA; Howard BV; Grundy SM
    J Clin Invest; 1985 Aug; 76(2):575-85. PubMed ID: 4031063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.